APA (7th ed.) Citation

K, U., N, S., T, Y., S, A., K, T., M, I., . . . A, M. (2026). Histopathological evaluation of dopamine receptor D2 expression in symptomatic gonadotroph pituitary neuroendocrine tumors: A case series including a rare metastatic case responsive to a dopamine agonist. Brain tumor pathology, 43(3), 123. https://doi.org/10.1007/s10014-025-00521-3

Chicago Style (17th ed.) Citation

K, Uekawa, et al. "Histopathological Evaluation of Dopamine Receptor D2 Expression in Symptomatic Gonadotroph Pituitary Neuroendocrine Tumors: A Case Series Including a Rare Metastatic Case Responsive to a Dopamine Agonist." Brain Tumor Pathology 43, no. 3 (2026): 123. https://doi.org/10.1007/s10014-025-00521-3.

MLA (9th ed.) Citation

K, Uekawa, et al. "Histopathological Evaluation of Dopamine Receptor D2 Expression in Symptomatic Gonadotroph Pituitary Neuroendocrine Tumors: A Case Series Including a Rare Metastatic Case Responsive to a Dopamine Agonist." Brain Tumor Pathology, vol. 43, no. 3, 2026, p. 123, https://doi.org/10.1007/s10014-025-00521-3.